Teledyne Technologies announced it has agreed to acquire Varex Imaging for approximately $1.1 billion, a move that will significantly increase Teledyne's presence in the healthcare market. Varex specializes in X-ray imaging components for medical and industrial applications, complementing Teledyne's existing digital imaging technologies with minimal overlap. The acquisition is expected to close early next year, pending regulatory approvals.

Spotify is implementing a new "AI Personas" label for artist profiles and songs created by artificial intelligence to provide listeners with more transparency. The company aims for consumers to distinguish between human and AI-generated artists. Spotify also stated it will not recommend AI Persona songs in suggested playlists unless explicitly opted into by listeners.

Intellinum, a provider of barcode labeling and mobility solutions, has achieved "Oracle Validated: Oracle Fusion Cloud Application Expertise." This recognition is for its FlexiPro Label integration with Oracle Fusion Cloud Supply Chain & Manufacturing (SCM), ensuring the solution aligns with Oracle's integration standards. FlexiPro Label enhances Oracle Cloud SCM's native labeling by providing enterprise-ready label design, printing, and management, triggered automatically by key transactions to improve accuracy, compliance, and traceability.

Rackspace Technology (RXT) reported wider-than-expected losses and slightly missed revenue forecasts for Q2 2026. Despite the misses, the stock rose due to investor focus on the company's strategic pivot into enterprise artificial intelligence (AI) infrastructure, including a significant partnership with AMD. The company is actively shifting away from lower-margin public cloud services towards higher-margin enterprise AI offerings and expects improved free cash flow in the second half of 2026.

A recent Gartner survey reveals that while 93% of audit leaders use AI, only 38% have a defined AI strategy. The survey, conducted in 2026 among 743 audit professionals, indicates that AI applications in internal audit primarily focus on isolated tasks like engagement preplanning and drafting issues, rather than strategic transformations or comprehensive audit testing. This suggests a high adoption rate but a lack of strategic integration, hindering AI's full potential to deliver better strategic insights and transform audit processes.

This article examines whether Western Digital (WDC) is a good investment based on Wall Street analyst recommendations. While analysts show strong optimism with an average brokerage recommendation (ABR) of 1.44 (between Strong Buy and Buy), the article cautions against relying solely on these ratings due to potential bias. It suggests using the Zacks Rank, a proprietary stock rating tool based on earnings estimate revisions, as a more reliable indicator, noting that WDC currently holds a Zacks Rank #2 (Buy).

Fair Isaac Corporation reported strong Q3 2026 results with US$674.19 million in revenue and US$237.17 million net income, along with increased full-year guidance and over US$2.69 billion in share repurchases. Despite this positive financial performance, concerns persist among investors regarding competitive pressures in credit scoring, as lenders increasingly explore alternatives to FICO's traditional scores. The article suggests that while the higher guidance supports near-term earnings, the evolving competitive landscape remains a significant risk that investors should carefully consider.

The author continues to invest in Intuitive Surgical (ISRG) despite a 30.54% year-to-date decline, believing the company's "razor and razorblade" business model and its dominant position in surgical robotics make it a long-term compounder. Key factors include the growing installed base of da Vinci systems, the early stages of the dV5 supercycle with significant technological advancements, and a strong balance sheet with substantial cash and increasing free cash flow. The article highlights that ISRG faces minimal soft-tissue competition from alternatives like Medtronic's Hugo or Johnson & Johnson's Ottava, which are still in early or pre-commercial stages.

IBM and Together AI have announced a significant collaboration worth $240 million, aimed at scaling AI deployments. This partnership focuses on enhancing enterprise AI capabilities and accelerating the adoption of AI solutions across various industries. The agreement underscores a commitment to integrating advanced AI technologies more broadly into business operations.

Abbott and Google Health have announced a multi-year partnership to integrate glucose insights from Abbott's Lingo biowearable with Google's AI and consumer technology. This collaboration aims to provide personalized metabolic insights through the Google Health app, helping users understand how daily behaviors affect their glucose levels and overall well-being. The partnership also includes a large-scale research study to inform AI coaching and future Lingo features, addressing the rising global rates of metabolic health challenges.